Trading Signals: CEMI Stock Price Prediction and Forecast (Wed. Nov. 26, 2003 - Wed. Jul. 21, 2021)(Chembio Diagnostics Inc)
| CEMI latest price $5.5200 (-8.31%) ($5.5000 - $6.0700) on Mon. Aug. 5, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.97% (three month average) | RSI | 42 | Latest Price | $5.5200(-8.31%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CEMI declines -1.7% a day on average for past five trading days. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CEMI advance at 0% a week (0% probability) ARKG(11%) IGOV(8%) XBI(8%) SHY(7%) ARKK(5%) | Factors Impacting CEMI price | CEMI will decline at least -1.485% in a week (0% probabilities). UNG(-11%) IFRA(-7%) XLU(-5%) XLP(-5%) VXX(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.485% (StdDev 2.97%) | Hourly BBV | 0 () | Intraday Trend | -7.2% | | | |
|
Resistance Level | $5.96 | 5 Day Moving Average | $5.95(-7.23%) | 10 Day Moving Average | $6.03(-8.46%) | 20 Day Moving Average | $5.96(-7.38%) | To recent high | -29.7% | To recent low | 0% | Market Cap | $111m | | | | Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY. |